Education, development, and campaigning for patient access to medical cannabis
Althea’s mission is to alleviate the suffering of patients with debilitating conditions through education, development, and campaigning for patient access to medical cannabis.
The primary...
Meet Khiron: the company providing cannabis trials with medical products
Khiron Life Sciences is a cannabis pharmaceuticals company with operations and a presence across Latin America, joint venture entry into the US consumer market,...
Cloud 9: high quality standards for hemp and cannabis products
Cloud 9 Group leverages its strong principles and high quality standards to produce premium hemp and cannabis products.
The Cloud 9 Group of private companies...
EUMCA calls for reduction of lower THC limit in German cannabis extracts
The European Medical Cannabis Association (EUMCA) is calling for the reduction of the lower THC limit in cannabis extracts from 1% to 0.2% to...
Exploring growth in the European medical cannabis market
Luc Springinsfeld of leading investment bank Bryan, Garnier & Co explores the European medical cannabis market and the rise of medical cannabis investment in...
Patient access to cannabis in the UK: Cellen breaks down barriers
Unfortunately, it remains challenging for UK patients to access medical cannabis – but rapidly expanding provider Cellen Therapeutics is working to break down those...
Khiron Life Sciences: expanding into Europe with patient focus
Global cannabis leader Khiron Life Sciences is expanding into the European sector with a patient focus.
Khiron Life Sciences is a vertically integrated global cannabis...
The wellness revolution with Medicaleaf
A coronavirus ‘good news’ story from innovator Medicaleaf, looking at the wellness revolution.
When a group of relative strangers with myriad strengths, experience and expertise...
Malta’s COVID-19 response secures cannabis industry growth
Malta Enterprise has played a pivotal role in ensuring support for research and industry in the face of the COVID-19 epidemic. It says Malta's...
Vitality Hemp: greener home living with British hemp
British company Vitality Hemp is working to embrace the environmental and economic potential of the hemp industry.
The British hemp industry is expanding into a...
Medical cannabis patients use fewer healthcare resources
A new study has revealed that medical cannabis patients use fewer healthcare resources and report improved quality of life.
To date, there has been minimal...
Increased European cannabis demand amidst COVID-19 pandemic
MCN’s partner New Frontier Data explores the effect of COVID-19 European cannabis demand, including consumer trends and the economic future.
Despite inevitable regulatory delays due...
BBS grows as Australia becomes the new leader in medicinal cannabis
CEO John Dagas is optimistic about the medicinal cannabis market growth in Australia and the positioning of BBS to be a leader in Oceania.
Although...
UK Medical Cannabis Registry launched today by Sapphire Medical Clinics
Today marks the launch of Sapphire Medical Clinic’s Medical Cannabis Registry for patients in the UK.
Sapphire Medical Clinics has today launched its Medical Cannabis...
Leafcann Group: how do we futureproof the medicinal cannabis industry?
Leafcann Group CEO Elisabetta Faenza explores regulatory reform, best practice standards and the future of the medicinal cannabis market.
Many industries around the world are...
CBD and inflammatory bowel disease: not just a gut feeling
IcBD has developed a CBD formulation which could be the answer to inflammatory bowel disease.
In recent years, few topics have been as hot and...
Greater Cannabis launches CBD oral tab with European partner Symtomax
Greater Cannabis Company has announced that it has launched its first cannabidiol (CBD) consumer product - OralTabs - with European partner Symtomax.
Greater Cannabis Company,...
Cannabis concentrates boost THC blood levels but do not get you ‘higher’
A new study has shown that cannabis concentrates do increase THC levels in the blood, but do not actually have a stronger psychoactive impact...
The Greater Cannabis Company completes oral CBD patch shipment
The first shipment of an innovative oral CBD patch has now been completed.
Greater Cannabis Company Inc, a biopharmaceutical company focussed on the development and...
Evidence still unclear on whether cannabis affects risk of stroke
Whether cannabis increases a person’s risk of suffering a stroke is still unclear. A new study explored whether there was a connection between recent...
